Chugai Pharmaceutical Co., Ltd.

{
  "main_header": {
    "sid": 1128557,
    "name": "Chugai Pharmaceutical Co., Ltd.",
    "stock_name": "Chugai Pharmaceutical Co., Ltd.",
    "full_name": "Chugai Pharmaceutical Co., Ltd.",
    "name_url": "stocks-analysis/chugai-pharmaceutical-co-",
    "exchange": 121,
    "exchangecode": "TKS",
    "country_id": 23,
    "currency": "JPY",
    "cmp": "8,608.00",
    "chg": -94,
    "chgp": "-1.08%",
    "dir": -1,
    "prev_price": "8,702.00",
    "mcapval": "13,855,583.87",
    "mcap": "Large Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "Japan Nikkei 225",
    "isin": "JP3519400000",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "7.56 M",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/chugai-pharmaceutical-co--1128557-121&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Chugai Pharmaceutical Co., Ltd. Reports Strong Financial Performance in Q2 2025",
        "link": "https://www.marketsmojo.com/news/mojo-premium/chugai-pharmaceutical-co-ltd-enters-mojo-stocks-strategy-with-strong-financials-3690072",
        "imagepath": "",
        "date": "2025-11-11 16:16:06",
        "description": "<p><strong>Chugai Pharmaceutical Co., Ltd.</strong> has demonstrated impressive financial results for the quarter ending June 2025, showcasing a robust operational performance that has caught the attention of investors. The company, recognized as a large-cap entity, has reported its highest operating cash flow to date, amounting to JPY 464,601 MM.</p>\n\n<p>In addition to its strong cash flow, <strong>Chugai Pharmaceutical</strong> has also declared a record dividend per share for the half-year, set at JPY 3.59. This reflects the company's commitment to returning value to its shareholders, further evidenced by a significant dividend payout ratio of 211.73%.</p>\n\n<p>The financial health of <strong>Chugai Pharmaceutical</strong> is further underscored by its substantial cash and equivalents, which stand at JPY 1,972,159 MM. This strong liquidity position allows the company to navigate market fluctuations effect..."
      }
    ],
    "total": 6,
    "sid": "1128557",
    "stock_news_url": "https://www.marketsmojo.com/news/chugai-pharmaceutical-co--1128557"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Chugai Pharmaceutical Co., Ltd. Reports Strong Financial Performance in Q2 2025

2025-11-11 16:16:06

Chugai Pharmaceutical Co., Ltd. has demonstrated impressive financial results for the quarter ending June 2025, showcasing a robust operational performance that has caught the attention of investors. The company, recognized as a large-cap entity, has reported its highest operating cash flow to date, amounting to JPY 464,601 MM.

In addition to its strong cash flow, Chugai Pharmaceutical has also declared a record dividend per share for the half-year, set at JPY 3.59. This reflects the company's commitment to returning value to its shareholders, further evidenced by a significant dividend payout ratio of 211.73%.

The financial health of Chugai Pharmaceutical is further underscored by its substantial cash and equivalents, which stand at JPY 1,972,159 MM. This strong liquidity position allows the company to navigate market fluctuations effect...

Read full news article

View All News